Patent details
EP4252003 Title: ANALYTICAL METHOD FOR GLYCOCONJUGATES USING A CAPILLARY-BASED IMMUNOASSAY SYSTEM
Basic Information
- Publication number:
- EP4252003
- PCT Application Number:
- IB2021061115
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP218192292
- PCT Publication Number:
- WO2022113048
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANALYTICAL METHOD FOR GLYCOCONJUGATES USING A CAPILLARY-BASED IMMUNOASSAY SYSTEM
- French Title of Invention:
- MÉTHODE D'ANALYSE POUR LES GLYCOCONJUGATES UTILISANT UN SYSTÈME "IMMUNOASSAY" À BASE DE CAPILLAIRES
- German Title of Invention:
- ANALYTISCHE METHODE FÜR GLYCOCONJUGATE MIT EINEM KAPILLARBASIERTEN IMMUNOASSAY-SYSTEM
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 02/04/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 08/04/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 05/03/2025
- Unitary Effect Registration Date:
- 08/04/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 30/11/2021
- Grant date:
- 05/03/2025
- EP Publication Date:
- 04/10/2023
- PCT Publication Date:
- 02/06/2022
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/03/2025
- EP B1 Publication Date:
- 05/03/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 30/11/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/02/2025
- Name:
- Janssen Pharmaceuticals, Inc.
- Address:
- 1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States (US)
Inventor
1
- Name:
- KRIEFTEWIRTH, Michael
- Address:
- Switzerland (CH)
2
- Name:
- PIANTA, Annalisa
- Address:
- Switzerland (CH)
3
- Name:
- GRIJPSTRA, Jan
- Address:
- Netherlands (NL)
4
- Name:
- CHAKKUMKAL, Anish
- Address:
- Netherlands (NL)
5
- Name:
- BIANCHI, Joëlle
- Address:
- Switzerland (CH)
6
- Name:
- KAGABO, Diane
- Address:
- Netherlands (NL)
7
- Name:
- REBER, Vera
- Address:
- Switzerland (CH)
8
- Name:
- MANI, Jan
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 20210768
- Priority Date:
- 30/11/2020
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- G01N 33/561; G01N 33/569;
Publication
European Patent Bulletin
1
- Issue number:
- 202510
- Publication date:
- 05/03/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202519
- Publication date:
- 07/05/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202519
- Publication date:
- 07/05/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|